Study reveals clues to how Eastern equine encephalitis virus invades brain cells
An atomic-level investigation of how Eastern equine encephalitis virus binds to a key receptor and gets inside of cells also has enabled the discovery of a decoy molecule that protects against the potentially deadly brain infection, in mice.
The study, from researchers at Washington University School of Medicine in St. Louis, is published Jan. 3 in the journal Cell. By advancing understanding of the complex molecular interactions between viral proteins and their receptors on animal cells, the findings lay a foundation for treatments and vaccines for viral infections.
An artificial intelligence approach to predicting personality types in dogs
A multi-disciplinary research team specializing in canine behavior and Artificial Intelligence has developed an AI algorithm that automates the high-stakes process of evaluating potential working dogs’ personalities. They hope to help dog training agencies more quickly and accurately assess which animals are likely to succeed long term in careers such as aiding law enforcement and assisting persons with disabilities. The personality test could also be used for dog-human matchmaking, helping shelters with proper placement, thus reducing the number of animals returned for not being a good fit with their adoptive families.
Revolution in Lung Healing: Penn Vet Researchers' Breakthrough Technique to Repair Damage from Flu and COVID-19
A groundbreaking study by a team of researchers at the University of Pennsylvania has unveiled promising new techniques for repairing lung tissue damaged by illnesses such as the flu and COVID-19. This collaborative effort, crossing multiple disciplines within Penn, represents a significant stride in medical science, potentially changing the way we approach respiratory recovery.
IDEXX's Record-Breaking Year: Surging Growth and Revolutionary Pet Healthcare Innovations
For the fourth quarter of 2023, IDEXX's revenues soared to $902 million, marking a robust 9% increase from the previous year on a reported basis and 8% on an organic basis. This growth was primarily driven by the Companion Animal Group ("CAG"), which saw a 10% rise in reported revenue and a 9% increase organically. The CAG Diagnostics segment, in particular, experienced an impressive 11% growth in recurring revenue on a reported basis and 10% organically, underlining the company’s strong market presence and innovative approach.
Merck Animal Health’s $1.3B Aqua Business Acquisition
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated (NYSE: ELAN) for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species; two related aqua manufacturing facilities in Canada and Vietnam; as well as a research facility in Chile. The acquisition is expected to be completed by mid-year 2024, subject to approvals from regulatory authorities and other customary closing conditions.
Phibro Animal Health Corporation Announces Chief Financial Officer Changes
Phibro Animal Health Corporation today announced that Glenn C. David has joined Phibro and will assume the role of Chief Financial Officer effective February 9, 2024. Mr. Richard Johnson, who is currently serving as Phibro’s interim Chief Financial Officer since September 29, 2023, will continue with Phibro for a period of time in an advisory capacity to ensure a smooth transition with his successor.